Admission Date:  [**2104-11-4**]              Discharge Date:   [**2104-11-7**]  Date of Birth:  [**2050-11-30**]             Sex:   M  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 695**] Chief Complaint: Elevated bilirubin  Major Surgical or Invasive Procedure: Percutaneous transhepatic cholangiogram and tube placement times 2 liver biopsy   History of Present Illness: 53-year-old male with a history of primary sclerosing cholangitis who underwent a common bile duct excision, [**Last Name (un) 44262**]-en-Y hepaticojejunostomy, cholecystectomy, true-cut biopsy of the right and left lobes of the liver performed on [**2102-7-31**] for benign bile duct stricture.
He had stopped his Actigall treatment and with reinstitution his alkaline phosphatase decreased to 478 in [**2103-11-22**].
He underwent an MRCP in [**Month (only) 404**] of this year that demonstrated diffuse biliary disease with strictures and dilatation consistent with PSC.
He presented for percutaneous transhepatic cholangiogram and a biopsy of his liver.
Physical Exam: General: no apparent distress, well appearing HEENT: neck supple, trachea midline Cardiac: regular rate and rhythm lungs: clear to auscultation bilaterally abdomen: soft, nontender, nondistended Extremities: no clubbing cyanosis or edema  Neuro: alert and oriented times three.
BILI CATH REM [**2104-11-6**]: IMPRESSION:  1) Successful removal of bilateral percutaneous transhepatic biliary drains.
Admission labs [**2104-11-4**] WBC-15.5*# RBC-4.25* Hgb-13.6* Hct-39.6* MCV-93 MCH-32.0 MCHC-34.4 RDW-13.1 Plt Ct-293 PT-13.1 PTT-27.2 INR(PT)-1.1 Glucose-115* UreaN-12 Creat-0.7 Na-141 K-4.0 Cl-103 HCO3-26 AnGap-16 ALT-131* AST-106* AlkPhos-618* TotBili-3.3* DirBili-2.4* IndBili-0.9 Calcium-9.6 Phos-2.6* Mg-1.6  Discharge labs: [**2104-11-7**] WBC-7.9 RBC-4.01* Hgb-12.9* Hct-37.0* MCV-92 MCH-32.1* MCHC-34.8 RDW-12.9 Plt Ct-247 Glucose-92 UreaN-12 Creat-0.6 Na-138 K-4.0 Cl-102 HCO3-26 AnGap-14 ALT-83* AST-39 AlkPhos-475* TotBili-1.4 Calcium-9.4 Phos-2.3* Mg-1.9  Brief Hospital Course: The patient was admitted to the surgical service after a percutaneous transhepatic cholangiogram placement of two percutaneous tubes.
He will have cipro empiric treatment on discharge  Medications on Admission: ursodiol 600mg tid, caltrate 600mg [**Hospital1 **], mesalamine 800mg [**Hospital1 **]  Discharge Medications: 1.
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**], MD, PHD[**MD Number(3) **]: LM [**Hospital Unit Name 3126**] CENTER Phone:[**Telephone/Fax (1) 673**] Date/Time:[**2104-11-11**] 11:00  Provider: [**Name10 (NameIs) **] [**Name8 (MD) **], MD Where: LM [**Hospital Unit Name 5628**] Phone:[**Telephone/Fax (1) 673**] Date/Time:[**2104-12-10**] 8:00  Provider: [**Name10 (NameIs) **] WEST,ROOM ONE GI ROOMS Where: GI ROOMS Date/Time:[**2104-12-23**] 10:00                                [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**] MD, [**MD Number(3) 709**]
